Clinical Use of Dornase Alfa Is Associated With a Slower Rate of FEV1 Decline in Cystic Fibrosis
Pediatric Pulmonology - United States
doi 10.1002/ppul.21388
Full Text
Open PDFAbstract
Available in full text
Date
March 24, 2011
Authors
Publisher
Wiley